A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris

Abstract

Lichen planopilaris (LPP) is an inflammatory variant of primary cicatricial alopecia. It causes severe hair loss and can lead to complete baldness. It is an autoimmune disease and can affect patients’ physical and mental lives greatly. JAK Inhibitors have been proven the most effective treatment option to treat LPP. This literature review aimed to analyze the effectiveness of JAK inhibitors in the management of LPP. In this review, we analyzed the ten most recent and comprehensive studies. The review has summarized existing case reports from clinical studies that have supported JAK inhibitors. The findings of the review show that JAK inhibitors are effective options for the treatment of LPP, however, there are still some concerns regarding the long-term safety of these drugs in the treatment of LPP. This review also highlights potential gaps in the literature and further need for research. Currently, there is a need for further research on the effectiveness of JAK inhibitors in the treatment of LPP.